Invasiveness gene signature predicts a favorable outcome also in estrogen receptor-positive primary breast cancers treated with adjuvant tamoxifen

Breast Cancer Research and Treatment

Volumn 111, Issue 2, 2008, Pages 389-390

  Coradini, Danila ^a   Gariboldi, Manuela ^a,b   Fedeli, Maya ^a   Pierotti, Marco A ^a   Daidone, Maria Grazia ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; ESTROGEN RECEPTOR; HERMES ANTIGEN; PROGESTERONE RECEPTOR; TAMOXIFEN;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INVASION; DISEASE FREE SURVIVAL; DNA MICROARRAY; FEMALE; GENE EXPRESSION; HUMAN; KAPLAN MEIER METHOD; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS;

ANTIGENS, CD24; ANTIGENS, CD44; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; NEOPLASM INVASIVENESS; RECEPTORS, ESTROGEN; TAMOXIFEN;

EID: 48149100611     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9777-3     Document Type: Letter

References (2)

1. R Liu X Wang GY Chen P Dalerba A Gurney T Hoey G Sherlock J Lewicki K Shedden MF Clarke 2007 The prognostic role of a gene signature from tumorigenic breast-cancer cells N Engl J Med 356 217 226
2. F Bertucci N Cervera D Birnbaum 2007 A gene signature in breast cancer N Engl J Med 356 1887